The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease [PDF]
Endocrinology and Metabolism, 2023 Background To determine whether baseline thyroid-stimulating immunoglobulin (TSI) bioassay or its early response upon treatment with an anti-thyroid drug (ATD) can predict prognosis of Graves’ disease (GD) in real-world practice.
Jin Yu +8 more
doaj +1 more source
The treatment of Graves' disease in children and adolescents [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2014 Graves' disease (GD) accounts for 10%-15% of thyroid disorders in children and adolescents. The use of antithyroid drugs as the initial treatment option in GD is well accepted.
Hae Sang Lee, Jin Soon Hwang
doaj +1 more source
Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years
Frontiers in Endocrinology, 2023 ObjectiveThe authors aimed to investigate the clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years.MethodsThe data of patients with antithyroid drug-induced aplastic anemia were retrieved from PubMed and ...
Ying Cheng +7 more
doaj +1 more source
Risk of Diabetes in Patients with Long-Standing Graves’ Disease: A Longitudinal Study [PDF]
Endocrinology and Metabolism, 2021 Background The detrimental effects of excessive thyroid hormone on glucose metabolism have been widely investigated. However, the risk of diabetes in patients with long-standing hyperthyroidism, especially according to treatment modality, remains ...
Eyun Song +10 more
doaj +1 more source
Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea [PDF]
Endocrinology and Metabolism, 2015 BackgroundAntithyroid drugs (ATDs) can lead to the development of agranulocytosis, which is the most serious adverse effect. Characteristics of ATD-induced agranulocytosis (AIA) have seldom been reported due to the rarity. In this study, we characterized
Hee Kyung Kim +11 more
doaj +1 more source
Study of Serum FSH, LH and Prolactin in Female Albino Rats by Experimentally Creating Hypothyroidism
Annals of Abbasi Shaheed Hospital and Karachi Medical & Dental College, 2021 Objective: The current research was draft to contrast the variation in levels of Prolactin (PRL), Luteinizing Hormone (LH) and Follicle stimulating hormone (FSH) in female rodents by experimentally producing hypothyroidism.
Amber ILyas +5 more
doaj +1 more source
Anesthetic management of a pregnant patient with uncontrolled hyperthyroidism for emergency caesarean section - a case report [PDF]
Novelty in Clinical Medicine, 2023 Background and Aims: Uncontrolled hyperthyroid patient in pregnancy for emergency caesarean section under general anaesthesia managed by giving antithyroid agents, beta blockers, dexamethasone preoperatively to inhibit peripheral conversion of T4 to T3 ...
Vasudha Govil +5 more
doaj +1 more source
Predicting remission of Graves' disease following treatment with antithyroid drugs
Клинический разбор в общей медицине, 2023 Graves' disease (GD) is among the most prevalent organ-specific diseases and is one of the most common causes of hyperthyroidism in regions with normal iodine supply.
Natalya V. Drogashevskaya +5 more
doaj +1 more source
High Throughput Pharmacovigilance Screening for Roflumilast Adverse Effects in Real-World Settings: A Sequence Symmetry Analysis. [PDF]
Basic Clin Pharmacol ToxicolABSTRACT Background Roflumilast is an add‐on therapy for COPD following exacerbations, but real‐world safety data in the United States are limited. Objective This study aimed to identify safety signals associated with roflumilast initiation through a high‐throughput signal detection algorithm. Methods Using sequence symmetry analysis (SSA), we analysed
Abdelaziz A, Gaber CE, Gupta P, Lee TA.
europepmc +2 more sources
Double Filtration Plasmapheresis for Thyroid Storm With Encephalopathy: A Case Report. [PDF]
J Clin ApherABSTRACT Thyroid storm is a life‐threatening endocrine emergency with a mortality rate of up to 17%. Standard treatment includes antithyroid drugs (ATD), β‐blockers, and glucocorticoids. However, some patients may require blood purification therapies, such as plasmapheresis, due to the ineffectiveness of standard treatments or contraindications like ...
Lin Q, Jin H, Xu Y, Xie Y, Zhou Y, Lu R.
europepmc +2 more sources